- Annual Meeting agenda slides
- INTERMACS Present and Future Summary of the Registry - J Kirklin
- Risk Factors for Death Transplant and Recovery - J Kirklin
- Risk Factors for Death Transplant and Recovery - D Naftel
- Risk Factor Paradigm for HeartMate II - Cowger
- Risk Factors for Adverse Outcomes with HeartWare HVAD - M Slaughter
- Outcomes of the First 100 Implants into PediMACS - J Rossano
- Registry Data Collection in Pediatrics - Too Much or Not Enough - D Rosenthal
- QoL in Pediatric VAD - How are we doing - K Uzark
- Alignment of Comparative Effectiveness through MedaMACS - M Shah
- Triage Guided by INTERMACS Profiles - L Stevenson
- Frailty and Quality-Adjusted Survival - J Lindenfeld
- Estimating Benefit in Ambulatory Patients - G Stewart
Morning Session 2
- Aortic Insufficiency - Framing the Issue Through INTERMACS - S Silvestry
- Challenges in Right Heart Failure - M Kiernan
- Hemolysis During MCS Therapy - J Katz
- Observation of an Increased Rate of VAD Thrombosis - N Moazami
- Analysis of VAD Thrombosis in the INTERMACS Database - M Acker
- Industry Perspective - J OConnell
Afternoon Session
- CMS Joint Commission INTERMACS - E Dunn
- Whose Uncertainty Which Equipose - F Pagani
- Debate Equipoise Exists for a Trail in the Less Ill Heart Failure Patient Disagree - A Boyle
- Debate Equipoise Exists for a Trail in the Less Ill Heart Failure patient Agree - I Pina
- Communicating VAD Information for Patient Decisions - L Allen
- A Proposal Utilization of Quality Outcomes and Cost Data to Make INTERMACS Indispensable to Centers - R Kormos
- B Value Based Care - The Role of INTERMACS - J Young
- A Canadian View on Effective Use of VADs - A Ducharme